Theseus Pharmaceuticals
NEWS
Theseus Pharmaceuticals was acquired by Cocentra Biosciences, LLC in 2024.
Life sciences organizations and companies strengthen their leadership teams and boards with these Movers & Shakers.
Omega raised $650 million, which it plans to invest in life science companies in the U.S. and Europe.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Companies across the biotech and biopharma industries recently reported a slew of new leadership appointments, several of which have been explicitly focused on the fields of oncology and precision medicine.
This morning, multiple companies announced hundreds of millions of dollars were raised in Series B rounds that will be used to advance therapeutics and business development programs.
IN THE PRESS